CORRADINI, PAOLO

CORRADINI, PAOLO  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 382 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study 2025 Stella, FedericoMagni, MartinaDe Philippis, ChiaraBramanti, StefaniaPennisi, MartinaCorradini, Paolo + Article (author) -
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial 2024 Corradini, PaoloRambaldi, Alessandro + Article (author) -
Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE study 2024 Barone, AngelicaCorradini, Paolo + Article (author) -
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 2024 Magni, MartinaBramanti, StefaniaPennisi, MartinaBermema, AnisaGuidetti, AnnaCorradini, Paolo + Article (author) -
Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study 2024 Corradini, Paolo + Article (author) -
The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real-world study on AIFA monitoring registries 2024 Passamonti, FrancescoCorradini, Paolo + Article (author) -
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial 2024 Dondi, AlessandraCavallo, FedericaCorradini, PaoloRe, Francesca + Article (author) -
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma 2024 Corradini, PaoloBolli, Niccolò + Article (author) -
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas 2024 Stella, FedericoCorradini, Paolo + Article (author) -
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia 2023 Mancini, AlessandroCorradini, PaoloPassamonti, Francesco + Article (author) -
Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial 2023 Stella, FedericoMarasco, VincenzoLevati, Giorgia VirginiaGuidetti, AnnaPennisi, MartinaVismara, CeciliaCorradini, Paolo + Article (author) -
Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas 2023 Guidetti, AnnaLorenzini, DanieleCorradini, Paolo + Article (author) -
Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc Italian expert panel 2023 Corradini, Paolo + Article (author) -
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study 2023 Corradini, Paolo + Article (author) -
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma 2023 Giannotta, ClaudiaCorradini, PaoloBolli, NiccolòMaura, Francesco + Article (author) -
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 2023 Corradini, PaoloOnida, Francesco + Article (author) -
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients 2023 Corradini, Paolo + Article (author) -
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy 2023 Guidetti, AnnaCorradini, Paolo + Article (author) -
A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents 2023 Corradini, Paolo + Article (author) -
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204) 2023 Corradini, Paolo + Article (author) -